Naar homepage     
Chronische Cerebro-Spinale Veneuze Insufficiëntie
Aanmelden op het CCSVI.nl forum
Lees Voor (ReadSpeaker)    A-   A+
Over CCSVI.nl | Zoeken | Contact | Forum
CCSVI.nl is onderdeel van de
Franz Schelling Website
meer informatie
  
Tuesday, December 13, 2011 5:30 AM | Karen Copeland Volg link

There is a comment section on the BW site. Please, Please put an appropriate comment on their site. as well as here at Locator. The more of the outside world who sees our comments, the more support we get. A few comments are barely noticed. A hundred are hard to ignore.


New killer on the block


http://www.businessweek.com/news/2011-12-12/novartis-confirms-patient-died-after-starting-gilenya-therapy.html



Dec. 12 (Bloomberg) -- Novartis AG said a multiple sclerosis patient died on Nov. 23 after starting treatment with Gilenya, the Basel, Switzerland-based drugmaker’s pill for MS.


The death is the first reported within 24 hours of the first Gilenya dose in more than 28,000 patients who have taken the drug, and a role for Gilenya in the death can’t be excluded or confirmed, spokesman Eric Althoff said today in an e-mailed statement.



http://www.businessweek.com/news/2011-12-12/novartis-confirms-patient-died-after-starting-gilenya-therapy.html